Microdosing is well-suited for individuals new to GLP-1 or GIP medications, or for those seeking a more gradual and personalized approach to weight management.
As the prevalence of obesity rises, MedBridge remains at the forefront of medical weight management, helping patients achieve lasting results with the support of cutting-edge therapies like GLP-1 medications
Studied in lipodystrophy and metabolic dysfunction models for depot-specific adipose tissue effects
Gunes Gunsel, G
In the case of eWAT, an increase in endogenous fatty acids following adherence to a HFD activates two sensors within adipocytes, Toll-like receptor 4(TLR4) and inflammasomes, which causes an influx of neutrophils to enter the eWAT, leading to increased levels of chemokine and cytokine expression (132)
The proportion of patients achieving NASH resolution in the absence of fibrosis progression was 40%, 36%, and 59% for the 0.1, 0.2, and 0.4 mg semaglutide arms, respectively, whereas the corresponding rate in the placebo arm was 17% (Newsome et al., 2021)